Skip to content

Achieve Life Sciences ACHV Operating Cash Flow

Operating Cash Flow at other companies

Pfizer logo
PfizerPFE
$2.62B+12.0%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
-$21.84M-34.1%
Philip Morris International logo
Philip Morris InternationalPM
-$399M-14.0%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's operating cash flow?
Achieve Life Sciences (ACHV) reported operating cash flow of -$6.93M in Q1 2026.
How has Achieve Life Sciences's operating cash flow changed year-over-year?
Achieve Life Sciences's operating cash flow increased by 37.5% year-over-year, from -$11.09M to -$6.93M.
What is the long-term trend for Achieve Life Sciences's operating cash flow?
Over 4 years (2021 to 2025), Achieve Life Sciences's operating cash flow has grown at a 13.9% compound annual growth rate (CAGR), from -$29.44M to -$49.47M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.